Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - TOTAL CURRENT ASSETS
Total Current Assets GERN - Geron Corporation
341 M
LAST VALUE
35.03%
2 YEAR CAGR
15.50%
5 YEAR CAGR
17.67%
10 YEAR CAGR